Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.180
+0.030 (0.95%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Myriad Genetics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Myriad Genetics stock has a consensus rating of "Hold" and an average price target of $5.39. The average 1-year stock price forecast is 69.50% higher than the current stock price, while the lowest is $3.00 (-5.66%) and the highest is $10 (+214.47%).
Price Target: $5.39 (+69.50%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Myriad Genetics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 6 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 11 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $4 → $3.2 | Sell | Reiterates | $4 → $3.2 | +0.63% | Aug 3, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $5.5 → $3 | Hold | Maintains | $5.5 → $3 | -5.66% | Aug 3, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 | Buy | Maintains | $8.5 | +167.30% | Jul 31, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $6 → $4 | Hold | Reiterates | $6 → $4 | +25.79% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
805.88M
from 824.50M
Decreased by -2.26%
Revenue Next Year
851.18M
from 805.88M
Increased by 5.62%
EPS This Year
-0.44
from 0.06
EPS Next Year
-0.29
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.